Blood News and Research

RSS

Young bone marrow transplants show promise in reversing Alzheimer's symptoms in mice

Researchers found that young bone marrow transplants rejuvenate aging immune cells, reducing Alzheimer's symptoms in mice models, suggesting a potential therapeutic approach for the disease.

4 Jun 2024

Family's rare telomere mutation reveals new insights into telomere flexibility and disease

Researchers discovered a rare telomere mutation (TTAGGT) in a family, revealing that human telomeres can tolerate non-canonical sequences, impacting telomere maintenance and disease.

4 Jun 2024

IgG from long COVID patients induces specific symptoms in mice, confirming autoimmunity's role

Researchers found that IgG from long COVID patients induces specific symptoms in mice, suggesting IgG's role in long COVID pathogenesis.

3 Jun 2024

Endocrine Society issues new clinical practice guideline on vitamin D use and testing

Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require testing for vitamin D levels, according to a new Clinical Practice Guideline issued today by the Endocrine Society.

3 Jun 2024

Endocrine disruptors disproportionately harm low-income women

Exposure to some endocrine-disrupting chemicals (EDCs) that harm the thyroid gland has increased over the past 20 years among U.S. women of childbearing age and pregnant women, especially among those with lower social and economic status, a new study finds.

3 Jun 2024

Novel male contraceptive gel suppresses sperm production faster than similar birth control methods

A novel male contraceptive gel combining two hormones, segesterone acetate (named Nestorone) and testosterone, suppresses sperm production faster than similar experimental hormone-based methods for male birth control, according to a new study.

3 Jun 2024

Most CDC-certified vitamin D tests are well calibrated, study says

Vitamin D tests certified by the U.S. Centers for Disease Control and Prevention (CDC) Clinical Standardization Programs (CSP) are well calibrated overall, according to a new study presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

High testosterone levels appear protective against the development of type 2 diabetes in men under 65

Testosterone appears protective against developing type 2 diabetes in men who are overweight or obese and under age 65, but not in men over that age, according to a study presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Stopping illicit steroids associated with depression and sexual dysfunction in men

Men who illicitly used steroids to boost muscle size and physical performance and have stopped in the past year have impaired sexual function compared with men currently using steroids, according to a study being presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Long-term study reveals safety of metformin use during pregnancy

Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

GLP-1 drugs may reduce pancreatitis risk in obese and diabetic patients

Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Breakthrough male contraceptive gel shows rapid results in clinical trial

Male contraceptive gel combines hormones for faster sperm production suppression.

3 Jun 2024

Excellent control of type 1 diabetes doesn't guarantee protection from heart disease

People who have had type 1 diabetes for more than 50 years without kidney complications may still be at substantial risk for heart disease, despite excellent control of blood pressure, cholesterol and blood sugar levels, according to a study presented Saturday at ENDO 2024, the Endocrine Society's annual meeting in Boston, Mass.

3 Jun 2024

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

Clinicians at Georgetown University's Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda).

3 Jun 2024

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

Whether sodium-glucose co-transporter 2 (SGLT2) inhibitors induce senolysis.

3 Jun 2024

New strategy targets rare B cells for effective HIV vaccine development

Germline-targeting epitope scaffold nanoparticles elicit rare broadly neutralizing antibody (bnAb) precursors against human immunodeficiency virus (HIV).

3 Jun 2024

Chronic caffeine intake may impact brain chemistry in Parkinson's disease

Regular high caffeine consumption affects dopamine function in patients with Parkinson’s disease, shows a new international study led by the University of Turku and Turku University Hospital in Finland. Caffeine consumption before undergoing diagnostic brain dopamine imaging may also affect the imaging results.

3 Jun 2024

US DoD funds Australian research on Parkinson's disease treatments

Researchers based at Australia’s Translational Research Institute (TRI) have received major funding from the United States Department of Defense (DoD) to develop Parkinson’s disease (PD) treatments by targeting the gut microbiome.

3 Jun 2024

New report highlights the urgent need for increased investment in MS research

A new report has revealed the prolonged time to diagnose multiple sclerosis (MS) and highlighted the urgent need for increased investment in MS research and enhanced awareness of the disease.

3 Jun 2024

Blood News and Research

Young bone marrow transplants show promise in reversing Alzheimer's symptoms in mice

Family's rare telomere mutation reveals new insights into telomere flexibility and disease

IgG from long COVID patients induces specific symptoms in mice, confirming autoimmunity's role

Endocrine Society issues new clinical practice guideline on vitamin D use and testing

Endocrine disruptors disproportionately harm low-income women

Novel male contraceptive gel suppresses sperm production faster than similar birth control methods

Most CDC-certified vitamin D tests are well calibrated, study says

High testosterone levels appear protective against the development of type 2 diabetes in men under 65

Stopping illicit steroids associated with depression and sexual dysfunction in men

Long-term study reveals safety of metformin use during pregnancy

Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

GLP-1 drugs may reduce pancreatitis risk in obese and diabetic patients

Breakthrough male contraceptive gel shows rapid results in clinical trial

Excellent control of type 1 diabetes doesn't guarantee protection from heart disease

Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial

Canagliflozin enhances senescent cell clearance, improving aging-related conditions

New strategy targets rare B cells for effective HIV vaccine development

Chronic caffeine intake may impact brain chemistry in Parkinson's disease

US DoD funds Australian research on Parkinson's disease treatments

New report highlights the urgent need for increased investment in MS research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News